PI3K inhibitor idelalisib enhances the anti-tumor effects of CDK4/6 inhibitor palbociclib via PLK1 in B-cell lymphoma
-
Published:2024-08
Issue:
Volume:597
Page:216996
-
ISSN:0304-3835
-
Container-title:Cancer Letters
-
language:en
-
Short-container-title:Cancer Letters
Author:
Hu Dingyao,
Cao Jiaowu,
Yu Hui,
Ding Ning,
Mi Lan,
Ye Yingying,
Li Miaomiao,
Wang Dedao,
Wu Jiajin,
Wang Xiaogan,
Song Yuqin,
Zhu JunORCID,
Ping Lingyan